JP Morgan Initiates Juno Therapeutics At Overweight By: Benzinga via Benzinga January 13, 2015 at 07:46 AM EST Analysts at JP Morgan initiated coverage on Juno Therapeutics Inc. (NASDAQ: JUNO) with a Overweight rating. The target price for ... Read More >>